ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2373

Low or High BMI Negatively Impacts RA Disease Activity in an Asian RA Cohort

Claire Teo1, KP Leong2, CM Woo3, X Tang3, J WL Tan4, TY Lian4 and ET Koh2, 1Rheumatology, Allergy and Immunology Department, Tan Tock Seng Hospital, Singapore, Singapore, 2Rheumatology/Allerg/Immunology, Tan Tock Seng Hospital, Singapore, Singapore, 3Clinical Research and Innovation Office, Tan Tock Seng Hospital, Singapore, Singapore, 4Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

The association of body mass index (BMI) with the outcomes of rheumatoid arthritis (RA) has been inconsistent in the literature. It is postulated that high BMI or obesity may have a diverse influence on RA risk, clinical activity and treatment response. The aim of our study is to investigate the association of BMI with RA disease activity and severity in a multi-ethnic RA cohort in Singapore.

Methods:

We reviewed data that was collected from November 2013 to March 2017 in a tertiary rheumatology centre. There were 288 patients (83.68% Chinese, 5.9% Malay, 9.72% Indian, 0.69% others; 87.85% female, 12.15% male). All patients fulfilled the ACR 1987 criteria for RA. Based on the World Health Organization classification, patients were categorized into 3 groups: low, normal and high BMI [<18.5kg/m² (underweight), 18.5-25kg/m² (normal weight) and >25kg/ m² (overweight) respectively]. Sociodemographic data, clinical features, disease activity (DAS28), laboratory variables (C-reactive protein, fasting lipid profile), functional status and co-morbidities were compared between the three BMI groups. Chi-square, T-test, Kruskal Wallis test and Wilcoxon rank sum test were used where appropriate. Statistical significance was defined as p-value < 0.05.

Results:

The mean age of the cohort was 44.7+11.85 years, the median RA duration 197.5 months, with no statistical difference between the three groups. Patients with normal BMI were the most likely to attain remission (DAS28<2.6) among the three groups (58.14% vs 81.43% vs 76.24%, p=0.038). Patients with normal BMI had a significantly lower C-reactive protein (mg/L) compared with the two other groups (4.1 vs 3.2 vs 4.6, p=0.0214). The low BMI group had a higher physician’s assessment of disease activity, but this did not reach statistical significance (12.47±18.13 vs 7.45±15.82 vs 9.18±18.51, p=0.236). The obese patients had significantly lower physical functioning scores in SF-36 (85 vs 75 vs 70, p=0.0198). Not unexpectedly, obese patients were more likely to have hypertension (p<0.0001), low HDL (p=0.004) and high TG (p=0.0001) levels, but there was no statistically significant difference for diabetes mellitus, ischemic heart disease, cardiovascular accident, liver and renal disease in the three groups. The three groups did not differ in gender, smoking status, prevalence of rheumatoid factor and anti-citrullinated peptide antibody, number of deformed joints, health assessment questionnaire (HAQ) scores and treatment.

Conclusion:

In our multi-ethnic cohort, patients with normal BMI appear to have the best RA control. High BMI should be considered a modifiable risk factor for poor RA outcome. Future studies should be done to investigate the relation of BMI and adiposity, as well as influence of frailty and sarcopenia on RA disease activity.


Disclosure: C. Teo, None; K. Leong, None; C. Woo, None; X. Tang, None; J. W. Tan, None; T. Lian, None; E. Koh, None.

To cite this abstract in AMA style:

Teo C, Leong K, Woo C, Tang X, Tan JW, Lian T, Koh E. Low or High BMI Negatively Impacts RA Disease Activity in an Asian RA Cohort [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/low-or-high-bmi-negatively-impacts-ra-disease-activity-in-an-asian-ra-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/low-or-high-bmi-negatively-impacts-ra-disease-activity-in-an-asian-ra-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology